IL44617A - Pyrimido (1,2-a) benzimidazole and 1,4-diazepino (1,2-a)benzimidazole derivatives and a process for their preparation - Google Patents
Pyrimido (1,2-a) benzimidazole and 1,4-diazepino (1,2-a)benzimidazole derivatives and a process for their preparationInfo
- Publication number
- IL44617A IL44617A IL44617A IL4461774A IL44617A IL 44617 A IL44617 A IL 44617A IL 44617 A IL44617 A IL 44617A IL 4461774 A IL4461774 A IL 4461774A IL 44617 A IL44617 A IL 44617A
- Authority
- IL
- Israel
- Prior art keywords
- addition salt
- acid addition
- benzimidazole
- reaction
- general formula
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 15
- 238000002360 preparation method Methods 0.000 title claims description 4
- PDTIISZQVLGION-UHFFFAOYSA-N 11H-[1,4]diazepino[1,2-a]benzimidazole Chemical class C=1N=CC=CN2C=1NC1=C2C=CC=C1 PDTIISZQVLGION-UHFFFAOYSA-N 0.000 title 1
- HOHWYQSDLRTVDK-UHFFFAOYSA-N pyrimido[1,2-a]benzimidazole Chemical compound N1=CC=CN2C3=CC=CC=C3N=C21 HOHWYQSDLRTVDK-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 22
- 150000003839 salts Chemical class 0.000 claims description 18
- 239000002253 acid Substances 0.000 claims description 16
- 239000002585 base Substances 0.000 claims description 13
- 229910052739 hydrogen Inorganic materials 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 150000001340 alkali metals Chemical class 0.000 claims description 3
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 238000009835 boiling Methods 0.000 claims description 2
- 150000007980 azole derivatives Chemical class 0.000 claims 1
- 239000000203 mixture Substances 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 230000002401 inhibitory effect Effects 0.000 description 10
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 241000700605 Viruses Species 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 229940058303 antinematodal benzimidazole derivative Drugs 0.000 description 4
- 150000001556 benzimidazoles Chemical class 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- FARSPAVQUKTXLF-UHFFFAOYSA-N 1h-benzimidazol-1-ium;chloride Chemical compound Cl.C1=CC=C2NC=NC2=C1 FARSPAVQUKTXLF-UHFFFAOYSA-N 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- 101000650578 Salmonella phage P22 Regulatory protein C3 Proteins 0.000 description 2
- 101001040920 Triticum aestivum Alpha-amylase inhibitor 0.28 Proteins 0.000 description 2
- 241000700618 Vaccinia virus Species 0.000 description 2
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 2
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 229940127557 pharmaceutical product Drugs 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 150000000183 1,3-benzoxazoles Chemical class 0.000 description 1
- MZYQPUDTBRVFCW-UHFFFAOYSA-N 1-benzyl-5,6-dimethylbenzimidazol-2-amine Chemical compound C1=2C=C(C)C(C)=CC=2N=C(N)N1CC1=CC=CC=C1 MZYQPUDTBRVFCW-UHFFFAOYSA-N 0.000 description 1
- HAEYZZSSSUIZAN-UHFFFAOYSA-N 1h-benzimidazol-1-ium-2-ylmethylazanium;dichloride Chemical compound Cl.Cl.C1=CC=C2NC(CN)=NC2=C1 HAEYZZSSSUIZAN-UHFFFAOYSA-N 0.000 description 1
- JWYUFVNJZUSCSM-UHFFFAOYSA-N 2-aminobenzimidazole Chemical compound C1=CC=C2NC(N)=NC2=C1 JWYUFVNJZUSCSM-UHFFFAOYSA-N 0.000 description 1
- 125000006290 2-hydroxybenzyl group Chemical group [H]OC1=C(C([H])=C([H])C([H])=C1[H])C([H])([H])* 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000991587 Enterovirus C Species 0.000 description 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical class C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 1
- 241000906446 Theraps Species 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910000272 alkali metal oxide Inorganic materials 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical class C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- XTEGARKTQYYJKE-UHFFFAOYSA-N chloric acid Chemical compound OCl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-N 0.000 description 1
- 229940005991 chloric acid Drugs 0.000 description 1
- AGVAZMGAQJOSFJ-UHFFFAOYSA-M cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1h-corrin-21-id-3-yl]propanoylamino]propan-2 Chemical compound [Co+2].N#[C-].OCC1OC(N2C3=CC(C)=C(C)C=C3N=C2)C(O)C1OP(O)(=O)OC(C)CNC(=O)CCC1(C)C(CC(N)=O)C2[N-]\C1=C(C)/C(C(C\1(C)C)CCC(N)=O)=N/C/1=C\C(C(C/1(CC(N)=O)C)CCC(N)=O)=N\C\1=C(C)/C1=NC2(C)C(C)(CC(N)=O)C1CCC(N)=O AGVAZMGAQJOSFJ-UHFFFAOYSA-M 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- -1 halide salt Chemical class 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 229910001502 inorganic halide Inorganic materials 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/50—1,3-Diazoles; Hydrogenated 1,3-diazoles
- A01N43/52—1,3-Diazoles; Hydrogenated 1,3-diazoles condensed with carbocyclic rings, e.g. benzimidazoles
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HURI508A HU168095B (de) | 1973-05-09 | 1973-05-09 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL44617A0 IL44617A0 (en) | 1974-06-30 |
| IL44617A true IL44617A (en) | 1977-02-28 |
Family
ID=11000919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL44617A IL44617A (en) | 1973-05-09 | 1974-04-12 | Pyrimido (1,2-a) benzimidazole and 1,4-diazepino (1,2-a)benzimidazole derivatives and a process for their preparation |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3941788A (de) |
| JP (1) | JPS5142119B2 (de) |
| AT (1) | AT334358B (de) |
| AU (1) | AU6765074A (de) |
| BE (1) | BE814661A (de) |
| DD (1) | DD111680A1 (de) |
| DE (1) | DE2420108A1 (de) |
| FR (1) | FR2228485B1 (de) |
| HU (1) | HU168095B (de) |
| IL (1) | IL44617A (de) |
| NL (1) | NL7405254A (de) |
| PL (1) | PL90457B1 (de) |
| SU (1) | SU504487A3 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5516785U (de) * | 1978-07-21 | 1980-02-02 | ||
| US6627624B1 (en) | 1999-04-02 | 2003-09-30 | Neurogen Corporation | Aryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors |
| US6380210B1 (en) * | 1999-04-02 | 2002-04-30 | Neurogen Corporation | Heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors |
| US6281237B1 (en) | 1999-04-02 | 2001-08-28 | Neurogen Corporation | N-phenyl benzimidazolecarboxamide and N-phenyl indolecarboxamide derivatives |
| US6271241B1 (en) | 1999-04-02 | 2001-08-07 | Neurogen Corporation | Cycloalkyl and aryl fused aminoalkyl-imidazole derivatives: modulators and GLP-1 receptors |
| DE10342503A1 (de) * | 2003-09-12 | 2005-04-14 | Merck Patent Gmbh | Benzyl-Benzimidazolylderivate |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3468888A (en) * | 1967-04-11 | 1969-09-23 | Smithkline Corp | 2-substituted pyrimido(1,2-a) benzimidazoles |
-
1973
- 1973-05-09 HU HURI508A patent/HU168095B/hu unknown
-
1974
- 1974-04-04 AT AT280574A patent/AT334358B/de not_active IP Right Cessation
- 1974-04-08 AU AU67650/74A patent/AU6765074A/en not_active Expired
- 1974-04-12 IL IL44617A patent/IL44617A/en unknown
- 1974-04-18 NL NL7405254A patent/NL7405254A/xx unknown
- 1974-04-24 DD DD178106A patent/DD111680A1/xx unknown
- 1974-04-24 US US05/463,686 patent/US3941788A/en not_active Expired - Lifetime
- 1974-04-25 DE DE2420108A patent/DE2420108A1/de active Pending
- 1974-04-30 FR FR7415057A patent/FR2228485B1/fr not_active Expired
- 1974-05-07 BE BE144017A patent/BE814661A/xx unknown
- 1974-05-08 SU SU2022055A patent/SU504487A3/ru active
- 1974-05-08 JP JP49050383A patent/JPS5142119B2/ja not_active Expired
- 1974-05-08 PL PL1974170921A patent/PL90457B1/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DD111680A1 (de) | 1975-03-05 |
| HU168095B (de) | 1976-02-28 |
| US3941788A (en) | 1976-03-02 |
| BE814661A (fr) | 1974-09-02 |
| DE2420108A1 (de) | 1974-11-28 |
| JPS5052096A (de) | 1975-05-09 |
| PL90457B1 (en) | 1977-01-31 |
| AU6765074A (en) | 1975-10-09 |
| SU504487A3 (ru) | 1976-02-25 |
| FR2228485A1 (de) | 1974-12-06 |
| JPS5142119B2 (de) | 1976-11-13 |
| AT334358B (de) | 1976-01-10 |
| NL7405254A (de) | 1974-11-12 |
| ATA280574A (de) | 1976-05-15 |
| IL44617A0 (en) | 1974-06-30 |
| FR2228485B1 (de) | 1977-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3949089A (en) | Substituted guanidine compounds as antifibrillatory agents | |
| US4767758A (en) | Pharmaceutical compositions containing thiophene compounds, and new thiophene compounds | |
| NO167775B (no) | Fremgangsmaate til transkoding av farge samt fargetranskoder som gjoer det mulig aa forbinde to forskjellige fargedefinisjonsutstyr. | |
| EP0148094A2 (de) | Anti-Tumormittel das O-Benzyliden-L-Ascorbinsäure oder ein Salz davon enthält, sowie Herstellung dieser letzteren Verbindung | |
| IL44617A (en) | Pyrimido (1,2-a) benzimidazole and 1,4-diazepino (1,2-a)benzimidazole derivatives and a process for their preparation | |
| NO155880B (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktivt 2-(2'hydroksy-3'-(1,1-dimetylpropylamino)-propoksy)-beta-fenylpropionfenon. | |
| DE1951748B2 (de) | Fluoranthendicarbonsäure-bis-(amino-alkylester) und antivirale Arzneimittel auf deren Basis | |
| RU2056416C1 (ru) | Производные тиомочевины, фармацевтическая композиция и способ лечения | |
| US4029666A (en) | Benzenesulfonyl-ureas and process for preparing them | |
| NO143084B (no) | Innretning for skallfjerning av marine krepsdyr, spesielt antarktisk krill. | |
| GB2148292A (en) | 4-chloro-furo-(3,4-c)-pyridine derivatives | |
| US3818000A (en) | 3-alkoxy-or 3-aryloxy-2-(diaryl-hydroxy)-methyl-propylamines | |
| US2695293A (en) | N, n'-substituted diamine compounds and method of making the same | |
| US3995046A (en) | Esters of 5-n-butylpyridine-2 carboxylic acid and pharmaceutical compositions containing these compounds | |
| JPH02258749A (ja) | ポリヒドロキシベンジルオキシプロパノールアミン | |
| US3433789A (en) | S-benzoyloxymethyl-thiamines | |
| US4820837A (en) | 1-hydroxy-oxo-5H-pyrido(3,2-a)phenoxazine-3-carboxylic acid esters | |
| US4148898A (en) | N-oxy-ajmaline and the use thereof in treating cardiovascular disorders | |
| US3028306A (en) | Hypertensive 2-amino-3alpha, 4, 5, 6, 7, 7alpha-hexahydrobenzoxazole method and topical dosage preparation | |
| US3784633A (en) | Imidazolinyl-ethyl-dithiocarbamic acid esters | |
| US3868463A (en) | Method of treating arrhythmia | |
| US3347862A (en) | Piperazine 2, 6-diiodo-4-nitrophenyl phosphate | |
| US3136803A (en) | Sulfonyloxy substituted alkylenediamines | |
| KR800001132B1 (ko) | 복소환 치환기를 가진 5-설파모일벤조산 유도체의 제조방법 | |
| HU186488B (en) | Process for producing pyridine derivatives and pharmaceutival compositions containing them as active agents |